 SAN CARLOS, Calif., June 02, 2022 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 9, 2022 at 8:30 a.m. ET 5:30 a.m. PT. 